These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34090117)

  • 1. Use of an exercise test to enhance sensing vector assessment and prevent inadequate subcutaneous implantable cardioverter-defibrillator discharges.
    Świerżyńska E; Sterliński M; Syska P; Sadowski K; Szumowski Ł
    J Electrocardiol; 2021; 67():73-76. PubMed ID: 34090117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oversensing issues leading to device extraction: When subcutaneous implantable cardioverter-defibrillator reached a dead-end.
    Noel A; Ploux S; Bulliard S; Strik M; Haeberlin A; Welte N; Marchand H; Klotz N; Ritter P; Haïssaguerre M; Bordachar P
    Heart Rhythm; 2020 Jan; 17(1):66-74. PubMed ID: 31295585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inappropriate subcutaneous implantable cardioverter-defibrillator shocks due to T-wave oversensing can be prevented: implications for management.
    Kooiman KM; Knops RE; Olde Nordkamp L; Wilde AA; de Groot JR
    Heart Rhythm; 2014 Mar; 11(3):426-34. PubMed ID: 24321235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How many patients fulfil the surface electrocardiogram criteria for subcutaneous implantable cardioverter-defibrillator implantation?
    Randles DA; Hawkins NM; Shaw M; Patwala AY; Pettit SJ; Wright DJ
    Europace; 2014 Jul; 16(7):1015-21. PubMed ID: 24351884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relation of QRS Duration to Clinical Benefit of Cardiac Resynchronization Therapy in Mild Heart Failure Patients Without Left Bundle Branch Block: The Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy Substudy.
    Biton Y; Kutyifa V; Cygankiewicz I; Goldenberg I; Klein H; McNitt S; Polonsky B; Ruwald AC; Ruwald MH; Moss AJ; Zareba W
    Circ Heart Fail; 2016 Feb; 9(2):e002667. PubMed ID: 26823498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biventricular implantable cardioverter defibrillator and inappropriate shocks.
    Srivathsan K; Bazzell JL; Lee RW
    J Cardiovasc Electrophysiol; 2003 Jan; 14(1):88-9. PubMed ID: 12625617
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eligibility for the Subcutaneous Implantable Cardioverter-Defibrillator in Patients With Hypertrophic Cardiomyopathy.
    Francia P; Adduci C; Palano F; Semprini L; Serdoz A; Montesanti D; Santini D; Musumeci B; Salvati A; Volpe M; Autore C
    J Cardiovasc Electrophysiol; 2015 Aug; 26(8):893-899. PubMed ID: 25996259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block.
    Biton Y; Zareba W; Goldenberg I; Klein H; McNitt S; Polonsky B; Moss AJ; Kutyifa V;
    J Am Heart Assoc; 2015 Jun; 4(7):. PubMed ID: 26124205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of inappropriate shocks from implantable cardioverter-defibrillators.
    Jagielski D; Zyśko D; Nadolny K; Wizowska J; Biel B; Banasiak W; Ponikowski P
    Wiad Lek; 2019; 72(7):1243-1246. PubMed ID: 31398149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of subcutaneous implantable cardioverter-defibrillator based on template ECG screening and ineligible surface ECG predicting factors in patients with hypertrophic cardiomyopathy in China.
    Guo L; Zhang M; Hu M; Wang B; Wang J; Zuo L; Yang W; Liu B; Liu L
    Heart Vessels; 2019 May; 34(5):851-859. PubMed ID: 30465278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brugada syndrome: Eligibility for subcutaneous implantable cardioverter-defibrillator after exercise stress test.
    von Hafe P; Faria B; Dias G; Cardoso F; Alves MJ; Alves A; Rodrigues B; Ribeiro S; Sanfins V; Lourenço A
    Rev Port Cardiol (Engl Ed); 2021 Jan; 40(1):33-38. PubMed ID: 33436324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease Severity and Exercise Testing Reduce Subcutaneous Implantable Cardioverter-Defibrillator Left Sternal ECG Screening Success in Hypertrophic Cardiomyopathy.
    Srinivasan NT; Patel KH; Qamar K; Taylor A; Bacà M; Providência R; Tome-Esteban M; Elliott PM; Lambiase PD
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.
    Kelly PA; Mann DE; Damle RS; Reiter MJ
    J Am Coll Cardiol; 1994 Jun; 23(7):1531-4. PubMed ID: 8195509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise stress test reveals ineligibility for subcutaneous implantable cardioverter defibrillator in patients with Brugada syndrome.
    Tachibana M; Nishii N; Morita H; Nakagawa K; Watanabe A; Nakamura K; Ito H
    J Cardiovasc Electrophysiol; 2017 Dec; 28(12):1454-1459. PubMed ID: 28800177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients.
    Rorris FP; Charitos C
    Heart Fail Rev; 2021 Jul; 26(4):763-765. PubMed ID: 33404997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous implantable cardioverter defibrillator indication in prevention of sudden cardiac death in difficult clinical situations: A French expert position paper.
    Probst V; Boveda S; Sadoul N; Marquié C; Chauvin M; Mondoly P; Gras D; Jacon P; Defaye P; Leclercq C; Anselme F
    Arch Cardiovasc Dis; 2020 May; 113(5):359-366. PubMed ID: 32334981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. His bundle pacing for newly acquired pacing needs in patients implanted with a subcutaneous implantable cardioverter defibrillator: A feasibility study based on the automated screening score and clinical cases.
    Gauthey A; Calle S; Accinelli S; Depuydt P; Garnir Q; Scavée C; Marchandise S; Wauters A; Bordachar P; de Pooter J; le Polain de Waroux JB
    J Cardiovasc Electrophysiol; 2020 Jul; 31(7):1793-1800. PubMed ID: 32412155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Moderate exercise training improves functional capacity, quality of life, and endothelium-dependent vasodilation in chronic heart failure patients with implantable cardioverter defibrillators and cardiac resynchronization therapy.
    Belardinelli R; Capestro F; Misiani A; Scipione P; Georgiou D
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):818-25. PubMed ID: 17001224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous Implantable Cardioverter Defibrillator in Patients With Hypertrophic Cardiomyopathy: An Initial Experience.
    Weinstock J; Bader YH; Maron MS; Rowin EJ; Link MS
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU; Goldenberg I; Moss AJ
    Eur Heart J; 2013 Aug; 34(29):2230-42. PubMed ID: 23729691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.